GK Software SE Formerly known as GK Software AG. GK Software SE is a Germany-based information technology (IT) company and retail software developer for corporations and local stores. It operates through two segments: GK/Retail and IT Services. The GK/Retail segment offers various software products and end-to-end solutions, including software for store device control and mobile merchandise management, for secure handling of business processes at traditional and mobile points of sale (POS), as well as software for task management, centralization of back office servers, facility administration, and promotion management, among others. The IT Services segment offers services for operating systems at store-based retailers, such as user support and monitoring, and maintenance of software and hardware. The Company has a number of wholly owned subsidiaries, such Eurosoftware s.r.o., Prudsys AG and AWEK GmbH, among others. It is active in the Czech Republic, Germany Switzerland, Russia, Ukraine, South Africa and the United States.

Heidelberger Druckmaschinen is engaged as a provider for the printing industry. Co.'s operating activities are divided into three segments: Heidelberg Equipment, Heidelberg Services and Heidelberg Financial Services. Co.'s Heidelberg Equipment segment primarily comprises new machinery business. Services, consumables, spare parts and remarketed equipment business are included in Co.'s Heidelberg Services segment. Co.'s Heidelberg Financial Services segment comprises sales financing business.

MorphoSys is engaged in development and commercialization of antibodies for therapeutic applications. Co. operates in two segments: Partnered Discovery, which operates therapeutic development programs for drug candidates in cooperation with biotechnology and pharmaceutical companies; and Proprietary Development, which is engaged in the development of therapeutic antibodies in the area of inflammatory disease and oncology on a proprietary basis. As of Dec 31 2013, Co.'s proprietary antibody compounds in clinical trials included MOR103 in the areas of rheumatoid arthritis and multiple sclerosis; MOR202 in the field of multiple myeloma; and MOR208 in the field of malignant B-cell diseases.

Steico SE is a Germany-based company engaged in the construction industry. The Company develops, produces and distributes ecological building products made from renewable raw materials. Its product portfolio consists of insulation solutions for roof, dry walls, ceiling and floor constructions, including STEICOflex, a flexible cavity insulation; STEICOformwork, robust formwork beams for economic formwork solutions; STEICOtherm, a solid heat insulation for roofs, walls and topping elements; STEICOuniversal, a sheathing board for all constructions; STEICOfloor, a floor insulation system protecting from heat and impact sound; STEICOglulam, structural engineered elements; STEICOprotect, removing the need for a ventilated cavity allowing for thinner wall constructions, and STEICOunderfloor, an impact sound insulation, among others. As of December 31, 2011, it operated through seven subsidiaries located in Poland, the United Kingdom and France.